Stay updated on Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Sign up to get notified when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.

Latest updates to the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page
- Check3 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.3, replacing the older version with a newer one. This is a metadata update and does not alter study details or user-facing content.SummaryDifference0.0%

- Check11 days agoChange DetectedA new publication citation has been added to the Publications section, listing a 2024 Diabetes Obes Metab article by Rubino et al. on patient-reported outcomes from STEP trials of semaglutide 2.4 mg in adults with overweight or obesity. This addition connects study results to recent external research.SummaryDifference0.0%

- Check18 days agoChange DetectedRecruitment status for the study has been updated to 'No longer looking for participants', indicating enrollment is closed. New user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the intervention labeling/version tag were updated.SummaryDifference0.2%

- Check25 days agoChange DetectedThe page revision tag has been updated from v3.5.4 to v3.5.5, signaling a new version of the page content.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4 in the page footer, indicating a template/backend release. No substantive page content or study data were altered.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page’s footer “Revision” label was updated from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov release/version update.SummaryDifference0.0%

Stay in the know with updates to Semaglutide Efficacy in Diabetes & Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide Efficacy in Diabetes & Obesity Clinical Trial page.